KS
Kanav Sethi
About Kanav Sethi
Data last updated:
Kanav Sethi is a Director at Curecross Lifetech Limited (since 2024), Director at Potent Biotech Limited (since 2023) and Director at Curecost Limited (since 2023), and holds 1 more current directorship. The companies operate in Paper and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Aug 2024 | 2024 | Active | ||
| Director | 08 May 2023 | 2023 | Active | ||
| Director | 06 May 2023 | 2023 | Active | ||
| Director | 21 Dec 2022 | 2022 | Active |
Board colleagues of Kanav Sethi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amrit Arora | 09146438 | Curecross Lifetech Limited , Potent Biotech Limited and 2 more | Director |
| Tilak Raj | 10748071 | Curecross Lifetech Limited , Potent Biotech Limited | Director |
| Renu Arora | 00227373 | Curecost Limited , Crosslands Life Sciences Limited | Director |
| Rohini Raman | 02558866 | Crosslands Life Sciences Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanav Sethi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanav Sethi
Kanav Sethi currently holds 4 directorships: Curecross Lifetech Limited (Director, since 20 Aug 2024); Potent Biotech Limited (Director, since 08 May 2023); Curecost Limited (Director, since 06 May 2023); Crosslands Life Sciences Limited (Director, since 21 Dec 2022).
Kanav Sethi was first appointed on 21 Dec 2022 as Director at Crosslands Life Sciences Limited. The most recent appointment on record is 20 Aug 2024 at Curecross Lifetech Limited.
The current boards of Kanav Sethi's companies include Amrit Arora (Curecross Lifetech Limited), Tilak Raj (Curecross Lifetech Limited), Renu Arora (Curecost Limited), Rohini Raman (Crosslands Life Sciences Limited).